Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Sign up for Newsletter  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace Asthma & COPD
Site Search:
    Home Engaged Innovation Patient Engagement Events News Careers Directory
 Event Advertisers   Show all: Event Advertisers

Click here to subscribe to Can Biotech Newsletters

 My Links   Show all: My Links

 CanBiotech News   Show all: CanBiotech News
New antiretroviral compound derived from sea sponges
Simon Fraser University   21 Mar 2018
Big Pharma, Big Changes: How Bayer And Johnson & Johnson Innovate
Innov8rs   15 Mar 2018
How Great Managers Can Drive Employee Engagement
Innovation Management   15 Mar 2018
Oregon Governor Signs Drug Price Transparency Bill
Regulatory Focus   15 Mar 2018
How to Successfully Collaborate with Industry
The Scientist   6 Mar 2018
NORD to Collaborate with FDA on Pilot Patient Engagement Activity
PR Newswire   28 Feb 2018
How can organisations align both strategy and teams so that the intended value is created?
Marcus Evans   28 Feb 2018
What are the skills and competencies needed for alliance managers?
Marcus Evans   28 Feb 2018
marcus evans to Host the 2nd Edition Patient Voice: Advocacy, Insights & Engagement Conference
Marcus Evans   12 Feb 2018
marcus evans to Host the Strategic Partnerships for External Innovation in Drug and Device Conference
Marcus Evans   12 Feb 2018
The Digital Pill
PharmaVoice   12 Feb 2018
How Well Do You Really Know Your Patients?
PharmaVoice   5 Feb 2018
The Convergence of Medicine and Technology
PharmaVoice   5 Feb 2018
Cold Spring case illustrates Bayh-Dole risk in midst of drug price controversy
Tech Transfer Central   24 Jan 2018
The CRISPR Patent Dispute
The Scientist   22 Jan 2018
Life science companies are missing out on the benefits of open innovation.
Nature   18 Jan 2018
Researchers Team Up with Patients to Build a Breast Cancer Database
The Scientist   16 Jan 2018
Can Boston And San Francisco Remain The Center Of Biopharma's Universe?
Life Science Leader   5 Jan 2018
Why We Should Talk to Patients Who Drop Out of Clinical Trials
Applied Clinical Trials   20 Dec 2017
If you liked pharma's innovation challenges in 2017, just wait. More are coming
FiercePharma   20 Dec 2017

 Patient Engagement News   Show all: Patient Engagement News

 Innovation Blogs and News   Show all: Innovation Blogs and News

Putting Humans at the Center of Health Care Innovation
An alternative model of healthcare is emerging-one that is human-centered design and co-creation, a set of approaches that can accelerate and humanize healthcare innovation.

Patient Advocacy Group Creates Patient Education Tools for MS
The education tool will support shared decision-making for patients with multiple sclerosis.

Drug delivery trends from Paris: Bluetooth, patient centricity and disposable tech
A patient-controlled injector and a prefilled pen for patients with hand dexterity issues were among the drug delivery technologies celebrated at PharmaPack Europe’s awards this year.

Why Pharma Needs A New Approach To Patient Engagement In Drug Development
Pharmaceutical companies have yet to maximally engage with patients to learn what they value before developing a product.

Available on demand: Improving patient adherence, engagement and outcomes through innovations in drug delivery

Solving Big Problems to Disrupt Patient Outcomes
By Mir Imran, Chairman and Chief Executive Officer, Rani Therapeutics
Over the years, I have spent considerable time thinking about the process of innovation and evaluating what has led me to be successful in creating products and companies.

Rebalancing the patient experience: 20 years of a pendulum swing
This article considers the evolution of the patient experience movement including moving from a belief system in which patients and families are solely the recipients of care to a model in which patients and families are co-designing treatment plans, systems and policies.

The Difference Between Patient Education and Health Literacy
Understanding the difference between patient education and health literacy can assist HCPs with targeted patient engagement programs.

Opinion: How an open approach to patents could help build a sustainable future
A protectionist approach to intellectual property is designed to protect and prolong the lifecycle of existing technologies, and allow innovators to capture the profits from their creations. In a paper published with colleagues from universities in Germany and India, we examined how this also makes it harder for new and more sustainable technologies to be developed and adopted.

You are invited to the Conference Board of Canada’s webinar Placemaking & Urban Mobility: Creating Healthy & Sustainable Communities on May 30th at 2 PM EDT. This session will outline the state of research and practice related to the use of Community Design Indicator that can be used to quantify and visualize healthy built environments.
Register online for $50. Your registration includes individual access to the live session, and a recording you can share with your whole organization.
Your campaign code to quote when registering is EBIO.

Patient engagement a new frontier for drug makers
Right now, any interaction between drug companies and patients typically comes after a drug has been developed and released, when drug makers look to patients to provide “patient reported outcomes” to determine whether a drug is having its intended effects and meeting patients’ expectations.
However, the push is to engage patients earlier in the process...

Converging Markets, Technologies, and Medical Advancements Drive New Opportunities and Innovations in Digital Healthcare
New opportunities and challenges are being created as healthcare delivery evolves through the continuum of care

Seniors for Seniors: A Mentorship Program to Prevent Social Isolation and Enable Healthy Living
A 5 seminar series to engage seniors on the topic of social isolation and enable participants to design a healthy living social network. The mentorship programs seeks seniors to empower other fellow seniors through discussion, analysis and social innovation.

Singapore QuickFire Challenge - Metabolic Disease Innovation
The QuickFire Challenge will award the entrepreneur, academic, and biotech researchers who submit the best ideas, technologies, or solutions holding the potential of making a major difference to the millions of people in Asia Pacific and around the world who suffer from metabolic diseases such as diabetes and obesity. Winners will be awarded with SGD100,000 project money, access to ETPL laboratory space and one year of mentorship and coaching by Johnson & Johnson Innovation, ETPL and SMART staff.

The initiative underscores Johnson & Johnson’s strong commitment to working in partnership to nurture the healthcare ecosystem in global innovation hotspots around the world, like Singapore, with the aim of positively impacting human health through innovation. The Challenge demonstrates Johnson & Johnson Innovation’s unique vision for collaboration in an open innovation model, aiming to combine Johnson & Johnson Innovation’s global reach and expertise with Singapore’s unique capabilities in innovation to identify breakthrough solutions for the diagnosis and/or treatment of metabolic diseases.

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.

The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.

Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here

Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.

Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions.

Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.

Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.

It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.

Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.

Innovation Communities
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.

Partnership between Pharma and Patients

Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.

Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.

Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.

Patient Engagement/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".

Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.

Continuing Reading More Innovation News and Blogs...

Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2018 CanBiotech™ Inc.